Literature DB >> 19636972

Glucose control and mortality in patients with severe traumatic brain injury.

Donald E G Griesdale1, Marie-Hélène Tremblay, Jonathan McEwen, Dean R Chittock.   

Abstract

INTRODUCTION: The optimal glucose range in patients with severe traumatic brain injury (TBI) remains unclear. The goal of this study was to examine the association of serum glucose levels on mortality in patients with severe TBI. As a secondary endpoint, we determined the risk of hyperglycemic and hypoglycemic events, and their association with mortality.
METHODS: We conducted a retrospective cohort study of patients admitted to the ICU between May 2000 and March 2006 with severe TBI (Glasgow Coma Scale ≤ 8) who survived at least 12 h. Average daily morning glucose levels for the first 10 days of admission were calculated and divided into quintiles.
RESULTS: A total of 170 patients were included in the analysis. We found no association between quintiles of mean daily morning glucose and hospital mortality. Episodes of hyperglycemia ( ≥ 11.1 mmol/l or 200 mg/dl) during the first 10 days occurred in 65% of patients (5.4% of all glucose measurements). Using multivariable regression, a single episode of hyperglycemia was associated with 3.6-fold increased risk of hospital mortality (95%CI: 1.2-11.2, P = 0.02). Hypoglycemia ( ≤ 4.4 mmol/l or 80 mg/dl) was present in 48% of patients (4.3% of all glucose measurements), and was not associated with mortality.
CONCLUSION: Any episode of hyperglycemia ( ≥ 11.1 mmol/l or 200 mg/dl) was associated with 3.6-fold increased risk of hospital mortality in patients with severe TBI and thus, should be avoided. Maintaining serum glucose ≤ 10 mmol/l appears to be a reasonable balance to avoid extremes of glucose control, but further studies are needed to determine the optimal glucose range.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19636972     DOI: 10.1007/s12028-009-9249-1

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  29 in total

1.  Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury.

Authors:  Paul Vespa; Robert Boonyaputthikul; David L McArthur; Chad Miller; Maria Etchepare; Marvin Bergsneider; Thomas Glenn; Neil Martin; David Hovda
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

2.  Persistent hyperglycemia is predictive of outcome in critically ill trauma patients.

Authors:  Grant V Bochicchio; Jin Sung; Manjari Joshi; Kelly Bochicchio; Steven B Johnson; Walter Meyer; Thomas M Scalea
Journal:  J Trauma       Date:  2005-05

3.  Relationship between admission hyperglycemia and neurologic outcome of severely brain-injured patients.

Authors:  B Young; L Ott; R Dempsey; D Haack; P Tibbs
Journal:  Ann Surg       Date:  1989-10       Impact factor: 12.969

4.  The impact of hyperglycemia on patients with severe brain injury.

Authors:  Elan Jeremitsky; Laurel A Omert; C Michael Dunham; Jack Wilberger; Aurelio Rodriguez
Journal:  J Trauma       Date:  2005-01

5.  The influence of hyperglycemia on neurological outcome in patients with severe head injury.

Authors:  A Rovlias; S Kotsou
Journal:  Neurosurgery       Date:  2000-02       Impact factor: 4.654

6.  Safety and efficacy of intensive insulin therapy in critical neurosurgical patients.

Authors:  Federico Bilotta; Remo Caramia; Francesca P Paoloni; Roberto Delfini; Giovanni Rosa
Journal:  Anesthesiology       Date:  2009-03       Impact factor: 7.892

7.  The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial.

Authors:  Federico Bilotta; Allison Spinelli; Federico Giovannini; Andrea Doronzio; Roberto Delfini; Giovanni Rosa
Journal:  J Neurosurg Anesthesiol       Date:  2007-07       Impact factor: 3.956

8.  Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients.

Authors:  Yaseen M Arabi; Ousama C Dabbagh; Hani M Tamim; Abdullah A Al-Shimemeri; Ziad A Memish; Samir H Haddad; Sofia J Syed; Hema R Giridhar; Asgar H Rishu; Mouhamad O Al-Daker; Salim H Kahoul; Riette J Britts; Maram H Sakkijha
Journal:  Crit Care Med       Date:  2008-12       Impact factor: 7.598

9.  Benefits and risks of tight glucose control in critically ill adults: a meta-analysis.

Authors:  Renda Soylemez Wiener; Daniel C Wiener; Robin J Larson
Journal:  JAMA       Date:  2008-08-27       Impact factor: 56.272

10.  Differential temporal profile of lowered blood glucose levels (3.5 to 6.5 mmol/l versus 5 to 8 mmol/l) in patients with severe traumatic brain injury.

Authors:  Regula Meier; Markus Béchir; Silke Ludwig; Jutta Sommerfeld; Marius Keel; Peter Steiger; Reto Stocker; John F Stover
Journal:  Crit Care       Date:  2008-08-04       Impact factor: 9.097

View more
  27 in total

1.  Intensive insulin therapy in the neurocritical care setting is associated with poor clinical outcomes.

Authors:  Carmelo Graffagnino; Ananda R Gurram; Bradley Kolls; DaiWai M Olson
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

2.  High blood glucose does not adversely affect outcome in moderately brain-injured rodents.

Authors:  Julia Hill; Jing Zhao; Pramod K Dash
Journal:  J Neurotrauma       Date:  2010-08       Impact factor: 5.269

3.  Glucose administration after traumatic brain injury improves cerebral metabolism and reduces secondary neuronal injury.

Authors:  Nobuhiro Moro; Sima Ghavim; Neil G Harris; David A Hovda; Richard L Sutton
Journal:  Brain Res       Date:  2013-08-29       Impact factor: 3.252

4.  Flavonoid derivative 7,8-DHF attenuates TBI pathology via TrkB activation.

Authors:  Rahul Agrawal; Emily Noble; Ethika Tyagi; Yumei Zhuang; Zhe Ying; Fernando Gomez-Pinilla
Journal:  Biochim Biophys Acta       Date:  2015-02-03

Review 5.  Making sense of gut feelings in the traumatic brain injury pathogenesis.

Authors:  Luiz Fernando Freire Royes; Fernando Gomez-Pinilla
Journal:  Neurosci Biobehav Rev       Date:  2019-05-16       Impact factor: 8.989

6.  7,8-Dihydroxyflavone facilitates the action exercise to restore plasticity and functionality: Implications for early brain trauma recovery.

Authors:  Gokul Krishna; Rahul Agrawal; Yumei Zhuang; Zhe Ying; Afshin Paydar; Neil G Harris; Luiz Fernando F Royes; Fernando Gomez-Pinilla
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-14       Impact factor: 5.187

7.  Continuous measurement of the cumulative amplitude and duration of hyperglycemia best predicts outcome after traumatic brain injury.

Authors:  Qiang Yuan; Hua Liu; Yang Xu; Xing Wu; Yirui Sun; Jin Hu
Journal:  Neurocrit Care       Date:  2014-02       Impact factor: 3.210

8.  Glucose administration after traumatic brain injury exerts some benefits and no adverse effects on behavioral and histological outcomes.

Authors:  Katsunori Shijo; Sima Ghavim; Neil G Harris; David A Hovda; Richard L Sutton
Journal:  Brain Res       Date:  2015-04-21       Impact factor: 3.252

Review 9.  Perioperative management of adult traumatic brain injury.

Authors:  Deepak Sharma; Monica S Vavilala
Journal:  Anesthesiol Clin       Date:  2012-06-13

10.  A prospective observational study of the relationship of critical illness associated hyperglycaemia in medical ICU patients and subsequent development of type 2 diabetes.

Authors:  Ivan Gornik; Ana Vujaklija-Brajkovic; Ivana Pavlic Renar; Vladimir Gasparovic
Journal:  Crit Care       Date:  2010-07-08       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.